Last updated: July 20, 2024
Sponsor: Tanta University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Colon Cancer Screening
Anesthesia
Treatment
Propofol combined with clonidine
Propofol
Clinical Study ID
NCT06507410
36264PR725/6/24
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-65 years.
Both sexes.
American Society of Anesthesiology (ASA) physical status I-II.
Patients undergoing colonoscopy.
Exclusion
Exclusion Criteria:
Patients had recent history of colonoscopy.
Previous colonic resection.
Severe heart failure (ejection fraction < 30%).
Known history of hypersensitivity to propofol or clonidine and any need foranesthetic drug administration other than the study protocol.
Study Design
Total Participants: 62
Treatment Group(s): 2
Primary Treatment: Propofol combined with clonidine
Phase:
Study Start date:
July 20, 2024
Estimated Completion Date:
September 01, 2024
Study Description
Connect with a study center
Tanta University
Tanta, El-Gharbia 31527
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.